Fundraising FoxImmuneoncia
2 known investors
Find your way into Immuneoncia
Sign up to find every way you can get introduced to Immuneoncia
- Your email: who you already know at Immuneoncia, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Immuneoncia team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Immuneoncia develops immuno-oncology cancer therapeutics, including antibody drugs targeting PD-L1 and CD47, with a program targeting both CD47 and PD-L1 simultaneously. Based in South Korea, the company works to advance immune-based cancer treatments.
Investors · 2
Frequently asked questions
- What does Immuneoncia do?
- Immuneoncia develops immuno-oncology cancer therapeutics, including antibody drugs targeting PD-L1 and CD47, with a program targeting both CD47 and PD-L1 simultaneously. Based in South Korea, the company works to advance immune-based cancer treatments.
- Who are Immuneoncia's investors?
- Immuneoncia's investors include LB Investment, Premier Partners.